CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clearside Biomedical, Inc.

CLSD
$2M
Micro Cap
NASDAQPharmaceutical Preparations🇺🇸North AmericaALPHARETTA32 employees

Drugs in Pipeline

8

Phase 3 Programs

2

Upcoming Catalysts

0

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

CLSD News
Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Market-Implied Move
Regulatory Approvals

Frequently asked questions

What is in Clearside Biomedical, Inc.'s drug pipeline?

CatalystAlert tracks 8 drug candidates in Clearside Biomedical, Inc.'s (CLSD) pipeline across Phase 3, Phase 2. Its lead program is 4mg CLS-TA Suprachoriodal Injection (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Clearside Biomedical, Inc.'s next FDA catalyst?

CatalystAlert tracks every upcoming catalyst for Clearside Biomedical, Inc. (CLSD) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track CLSD biotech catalysts?

Add CLSD to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Clearside Biomedical, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply